Form D · Other Health Care

SpyGlassPharma, Inc.

Aliso Viejo, CA · CIK 0001778922

Offering snapshot reported Jun 5, 2025 · SEC filing

Reported sold
$75M
Offering amount: $75M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 30, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 5, 2025Initial$74,999,989No comparison10SEC filing
Jul 11, 2023Initial$40,009,993No comparison7SEC filing
Jan 5, 2021Initial$13,749,996No comparison4SEC filing
Jun 5, 2019Initial$6,032,351No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-548147

Source: Form D, filed Jun 5, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ali Behbahani Director
Tak Cheung Director
Malik Kahook Director, Executive
Bilal Khan Director
Jake Merrill Director
Patrick Mooney Director, Executive
Kirk Nielsen Director
Geoff Pardo Director
Zach Scheiner Director
Glenn Sussman Director, Executive
Cynthia Yee Director
Roger Zhang Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
27061 Aliso Creek Road Suite 100
Aliso Viejo, CA, 92656